Albert Bourla insider trades
Open-market stock purchases and sales by Albert Bourla, Chairman & CEO at Pfizer Inc, from SEC Form 4 filings since Feb 24, 2014.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 15, 2026 | PFE Pfizer Inc | Bought (not open market) | $598 |
| May 29, 2026 | PFE Pfizer Inc | Bought (not open market) | $602 |
| May 15, 2026 | PFE Pfizer Inc | Bought (not open market) | $608 |
| Apr 30, 2026 | PFE Pfizer Inc | Bought (not open market) | $587 |
| Apr 15, 2026 | PFE Pfizer Inc | Bought (not open market) | $598 |
| Apr 14, 2026 | PFE Pfizer Inc | Bought (not open market) | $24.7K |
| Mar 31, 2026 | PFE Pfizer Inc | Bought (not open market) | $590 |
| Mar 13, 2026 | PFE Pfizer Inc | Bought (not open market) | $43.3K |
| Mar 3, 2026 | PFE Pfizer Inc | Bought (not open market) | — |
| Feb 25, 2026 | PFE Pfizer Inc | Bought (not open market) | — |
| Feb 25, 2026 | PFE Pfizer Inc | Sold (not open market) | $225K |
| Feb 25, 2026 | PFE Pfizer Inc | Sold (not open market) | $12.6M |
| Feb 12, 2026 | PFE Pfizer Inc | Bought (not open market) | $79.2K |
| Jan 14, 2026 | PFE Pfizer Inc | Bought (not open market) | $2K |
| Dec 31, 2025 | PFE Pfizer Inc | Bought (not open market) | $598 |
| Dec 15, 2025 | PFE Pfizer Inc | Bought (not open market) | $608 |
| Nov 28, 2025 | PFE Pfizer Inc | Bought (not open market) | $592 |
| Nov 14, 2025 | PFE Pfizer Inc | Bought (not open market) | $601 |
| Oct 31, 2025 | PFE Pfizer Inc | Bought (not open market) | $592 |
| Oct 15, 2025 | PFE Pfizer Inc | Bought (not open market) | $610 |
| Oct 14, 2025 | PFE Pfizer Inc | Bought (not open market) | $2K |
Companies traded
- PFE Pfizer Inc: 5 sales, last Jun 15, 2026